A novel CD69 binding ankyrin repeat protein (Ankyron®) enables detection of early activated and antigen-specific T cells in pigs

Dr Bettin completed her postdoctoral research at the University of Veterinary Medicine Vienna, focusing on vaccine development in the pig model. She recently joined the Vaccine and Infectious Disease Organization (VIDO) as a Principal Scientist, where her research focuses on porcine T-cell biology, particularly in mucosal tissues.

In this video, she’ll present a novel CD69-binding Ankyron and demonstrate its potential for detecting early activated and antigen-specific T cells in pigs.